A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome

Lucy S. French, Carla B. Mellough, Fred K. Chen, Livia S. Carvalho

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)


Usher syndrome is a genetic disorder causing neurosensory hearing loss and blindness from retinitis pigmentosa (RP). Adaptive techniques such as braille, digital and optical magnifiers, mobility training, cochlear implants, or other assistive listening devices are indispensable for reducing disability. However, there is currently no treatment to reduce or arrest sensory cell degeneration. There are several classes of treatments for Usher syndrome being investigated. The present article reviews the progress this research has made towards delivering commercial options for patients with Usher syndrome.

Original languageEnglish
Article number183
JournalFrontiers in Cellular Neuroscience
Publication statusPublished - 9 Jul 2020


Dive into the research topics of 'A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome'. Together they form a unique fingerprint.

Cite this